Literature DB >> 4853259

Morphine hyperglycaemia.

W Feldberg, K P Gupta.   

Abstract

1. To find the site where morphine acts when producing hyperglycaemia on injection into the cerebral ventricles in unanaesthetized cats, morphine sulphate was infused or injected through an implanted Collison cannula into different parts of the liquor space in an amount of 0.75 mg except on microinfusion into the posterior hypothalamus, when the amounts were 80 or 160 mug. The glucose was determined in blood samples collected from the inferior vena cava.2. Microinfusions of morphine into the posterior hypothalamus did not produce hyperglycaemia.3. Infusion of morphine into the liquor space at the entrance of the aqueduct or of the fourth ventricle produced hyperglycaemia. Any structures in the walls of the third ventricle as well as the peri-aqueductal grey are thus excluded as the site of action.4. Infusion of morphine into the subarachnoid space just above the corpora quadrigemina or below the ventral surface of the brain stem produced hyperglycaemia. With these routes the morphine does not enter any part of the ventricular cavities and the action would appear to be on structures at the ventral surface of the brain stem.5. Injection of morphine into the cisterna magna produces hyperglycaemia when the doses are larger than those already effective on injection into the cerebral ventricles. This also suggests an action on structures at the ventral surface of the brain stem, as this surface is reached more readily from the ventricles than from the cisterna.6. It is concluded that on injection into the cerebral ventricles, the morphine has to pass into the subarachnoid space, through the foramina of Luschka, in order to produce hyperglycaemia. It then reaches the ventral surface of the brain stem and probably acts there on structures in the upper part of the medulla oblongata.7. Infusion of morphine into the corpora quadrigemina near the caudal end of the superior corpora can produce profound hypoglycaemia.8. Anaesthesia depresses the morphine hyperglycaemia, but when the dose injected into the cerebral ventricles is increased four times or more, hyperglycaemia is also produced in pentobarbitone sodium anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4853259      PMCID: PMC1330898          DOI: 10.1113/jphysiol.1974.sp010539

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  9 in total

1.  Morphine-induced hyperglycemia in the cat.

Authors:  H L BORISON; B R FISHBURN; N K BHIDE; L E McCARTHY
Journal:  J Pharmacol Exp Ther       Date:  1962-11       Impact factor: 4.030

2.  THE ORIGIN OF THE HYPERGLYCAEMIC RESPONSE TO INTRACISTERNAL ADRENALINE IN THE CAT: THE SITE OF SYSTEMIC ABSORPTION AND OF CENTRAL ACTION OF ADRENALINE FROM THE SUBARACHNOID SPACE.

Authors:  D H SPROULL
Journal:  J Physiol       Date:  1963-12       Impact factor: 5.182

3.  Morphine hyperglycaemia: the site of action.

Authors:  W Feldberg; K P Gupta
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

4.  On the central sites for the antinociceptive action of morphine and fentanyl.

Authors:  A Herz; K Albus; J Metys; P Schubert; H Teschemacher
Journal:  Neuropharmacology       Date:  1970-11       Impact factor: 5.250

5.  The hyperglycaemic effect of morphine.

Authors:  W Feldberg; S V Shaligram
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

6.  Blood pressure effects obtained by drugs applied to the ventral surface of the brain stem.

Authors:  P G Guertzenstein
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

7.  Effect of pyrogen and antipyretics on prostaglandin acitvity in cisternal c.s.f. of unanaesthetized cats.

Authors:  W Feldberg; K P Gupta; A S Milton; S Wendlandt
Journal:  J Physiol       Date:  1973-10       Impact factor: 5.182

8.  Fever produced by prostaglandin E1.

Authors:  W Feldberg; P N Saxena
Journal:  J Physiol       Date:  1971-09       Impact factor: 5.182

9.  A vasodepressor effect of pentobarbitone sodium.

Authors:  W Feldberg; P G Guertzenstein
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

  9 in total
  16 in total

1.  Comparison of the hyperglycaemic effect of adrenaline and morphine introduced into the liquor space.

Authors:  P K Dey; W Feldberg; S Wendlandt
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

2.  Vasopressin release by nicotine: the site of action.

Authors:  W Feldberg; P G Guertzenstein; M Rocha e Silva
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

3.  Hyperglycaemia produced by drugs with analgesic properties introduced into the cerebral ventricles of cats.

Authors:  P K Dey; W Feldberg
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

Review 4.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

5.  The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides.

Authors:  R P Leach; M A Titheradge
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

6.  Morphine induces desensitization of insulin receptor signaling.

Authors:  Yu Li; Shoshana Eitan; Jiong Wu; Christopher J Evans; Brigitte Kieffer; Xiaojian Sun; Roberto D Polakiewicz
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Effects of morphine on glucose homeostasis in the conscious dog.

Authors:  P M Radosevich; P E Williams; D B Lacy; J R McRae; K E Steiner; A D Cherrington; W W Lacy; N N Abumrad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides.

Authors:  E H Allan; I C Green; M A Titheradge
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

9.  Opiates modulate insulin action in vivo in dogs.

Authors:  G A Werther; S Joffe; R Artal; M A Sperling
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

10.  Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man.

Authors:  R Caldara; G P Testori; C Ferrari; M Romussi; P Rampini; M Borzio; C Barbieri
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.